Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Fig. 2

Cryoablation of an aortocaval lymph node in the setting of acquired resistance during immune checkpoint inhibition. a Clinical timeline of therapy. b Poorly differentiated squamous cell carcinoma in lung tissue, mediastinal lymph node, and ablated aortocaval lymph node (H&E, original magnification X200) before cryoablation. c Baseline 18FDG PET/CT was obtained two months prior to cryoablation. Nine months follow-up PET imaging shows no recurrence of the metastatic lymph node

Back to article page